HELENE JOLLY: Open Payments
NPI 1619048451 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 53 payments from 12 companies in 2025. Trend: 2023 $1,205 · 2024 $3,404 · 2025 $1,186
Food & beverage: $1,121Education: $65
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $263 |
| Regeneron Healthcare Solutions, Inc. | 10 | $207 |
| ABBVIE INC. | 11 | $206 |
| Janssen Biotech, Inc. | 3 | $104 |
| Incyte Corporation | 4 | $102 |
| PFIZER INC. | 4 | $89 |
| LEO Pharma Inc. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
Products named: DUPIXENT, TREMFYA, OPZELURA, BOTOX, CIBINQO, ANZUPGO, RINVOQ, SPEVIGO.
Industry payments across CA — which companies pay providers there.
